U01.11.080 Recombinant parathyroid hormone

Learning Objectives

Differentiate the anabolic mechanism of Teriparatide and Abaloparatide from the antiresorptive effects of bisphosphonates. Master the pulsatile vs. continuous PTH paradox and identify the clinical utility and adverse effects of recombinant PTH analogs.


1. Mechanism: The Pulsatile PTH Paradox

While chronic elevation of endogenous Parathyroid Hormone (PTH) leads to bone resorption (as seen in hyperparathyroidism), intermittent (pulsatile) administration of recombinant PTH analogs actually stimulates osteoblastic activity and bone formation.

[Image showing pulsatile vs continuous PTH effect on bone formation]

Dosing Pattern Primary Target Cell Skeletal Outcome
Pulsatile (Once daily) Osteoblasts Anabolic (Increases bone mass).
Continuous (Chronic) Osteoclasts (via RANKL) Catabolic (Bone resorption/loss).

2. Clinical Use: Severe Osteoporosis

Unlike bisphosphonates, which only stop bone loss (antiresorptive), Teriparatide builds new bone. This makes it a primary choice for high-risk patients or those who have failed other therapies.

Drug Name Clinical Indication Duration Limit
Teriparatide Severe Osteoporosis; Glucocorticoid-induced osteoporosis. Typically limited to 2 years of total use.
Abaloparatide Postmenopausal women are at high risk for fracture. Similar anabolic profile to Teriparatide.

3. Adverse Effects and Metabolic Impact

Because Teriparatide is a PTH analog, it mimics the hormone’s systemic effects, which can lead to transient electrolyte shifts and vascular symptoms.

Adverse Effect Clinical Presentation / Monitoring
Hypercalcemia Transient increases in serum calcium levels are usually mild.
Vascular/CNS Dizziness and Tachycardia (often occurs shortly after injection).
Musculoskeletal Muscle spasms and leg cramps.
Black Box Warning Avoid in patients with Paget disease or prior radiation (Risk of Osteosarcoma in animal models).

Activity:


High-Yield Mnemonics & Tips:

  • “Teripara-Build”: Teriparatide Turns on the osteoblasts to Build bone.
  • Osteosarcoma Risk: Avoid in patients with unexplained high Alkaline Phosphatase (Paget’s) or radiation history to bone.
  • Step 1 Tip: If the question mentions a drug that increases bone mass rather than just preventing loss, they are likely describing an anabolic PTH analog.

Activity: